Hossein Maghsoudi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hossein Maghsoudi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Abdolmajid Narouie
Dept of Biotechnology, Ray Branch, Payame Noor University, Ray, Tehran, Iran
1 shared publication- Durdi Qujeq
Department of Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran
1 shared publication - Farzaneh Esmaily
Corresponding Authors: Mahsa M Amoli and Farzaneh Esmaily, EMRI, Dr Shariati Hospital, North Karegar St. Tehran 14114, Iran; ; Tel.: +98 21 88220037-8; FAX: 98 21 88220052
1 shared publication Fatemeh Nejat Pish‐Kenari
Student Research Committee Babol University of Medical Sciences Babol Iran
1 shared publication- Mahsa Mohammad Ammoli
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Samaneh Hagalahyari
Dept of Biotechnology, Ray Branch, Payame Noor University, Ray, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 1 August 2024
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Evaluation of IL 12 Gene Expression and Serum Levels of OxPL / apoB in Patients with Coronary Artery Disease
Background Atherosclerotic lesions are formed as a result of low-density lipoprotein (LDL) accumulation, which is produced by oxidizing enzymes and oxidized phospholipids (OxPL). Phospholipid oxide causes inflammation-inducing activation genes and hyper-inflammation in addition to the initiation of inflammation and expression of Th1 cytokines. Interleukin 12 (IL-12) is one of the most significant stimulants of inflammation and immune responses, among the Th1cytokines. Therefore, it may play a significant role in contributing to atherosclerosis. The quantitative expression of IL-12 mRNA, along with serum OxPL levels, has been analyzed in patients with coronary artery disease (CAD). Methods: Coronary angiography patients, aged 45 to 65 years and referred with chest pain, were examined. The patients were classified into normal coronary arteries (N = 38) and severe three-vessel involvement coronary arteries (N = 41). Molecular testing was performed using real-time PCR. Also, an ELISA test was used to check the OxPl level. Results Expression of IL12 in Individuals with coronary artery disease was increased but was not statistically significant.
- 1 August 2024
- Published by Scifiniti Publishing
- Vol. 1 (1) , 1-10
Open AccessEvaluation of IL 12 Gene Expression and Serum Levels of OxPL / apoB in Patients with Coronary Artery Disease
Background Atherosclerotic lesions are formed as a result of low-density lipoprotein (LDL) accumulation, which is produced by oxidizing enzymes and oxidized phospholipids (OxPL). Phospholipid oxide causes inflammation-inducing activation genes and hyper-inflammation in addition to the initiation of inflammation and expression of Th1 cytokines. Interleukin 12 (IL-12) is one of the most significant stimulants of inflammation and immune responses, among the Th1cytokines. Therefore, it may play a significant role in contributing to atherosclerosis. The quantitative expression of IL-12 mRNA, along with serum OxPL levels, has been analyzed in patients with coronary artery disease (CAD). Methods: Coronary angiography patients, aged 45 to 65 years and referred with chest pain, were examined. The patients were classified into normal coronary arteries (N = 38) and severe three-vessel involvement coronary arteries (N = 41). Molecular testing was performed using real-time PCR. Also, an ELISA test was used to check the OxPl level. Results Expression of IL12 in Individuals with coronary artery disease was increased but was not statistically significant.
- Open Access
- 27 March 2023
- Published by Wiley
Alcoholic Extract S.lavandulifolia Vahl Suppress TNFα,IL-1β,COX2, iNOS Gene Expression, and PGE2 and NO Production in Bovine Fibroblas-Like Synoviocyte and THP1
Osteoarthritis (OA) , known as an inflammatory disease, affects the quality of life of countless people all around the world. In this ex vivo study, the anti-inflammatory effects of alcoholic extract S. lavandulifolia Vahl were investigated. Anti-inflammatory effects S. lavandulifolia Vahl. was evaluated based on measuring the levels of mRNA expression of pro-inflammatory genes including TNF-α , iL-1β , COX-2, and iNOS in bovine fibroblast-like synoviocytes and the levels of NO and PGE2 in Human THP-1 cells. Cells were treated with 100 ng/ml LPS in both the absence and presence of Alcoholic Extract S. lavandulifolia Vahl (AESL) (7.5µg/ml) that had no cytotoxic effects, as measured with MTT and trypan blue assays. Results showed that S. lavandulifolia Vahl. downregulated TNF-α (41.24%), iL-1β (47.12%), COX-2 (44.92%), and iNOS (45.34%) expression in BFLS, downregulated TNF-α (56.8%), iL-6 (58.04%) and iL-18 (52.59%) in THP-1 activated cells and this suppression was paralleled by a significant reduction in PGE2 (52.12%) and NO (51.06%) in cellular supernatant of THP-1. For the first time, our results suggested that S. lavandulifolia Vahl exerts has anti-inflammatory effects through the suppression of TNF-α, IL-1β, COX-2, and iNOS in bovine fibroblast synoviocytes along with the reduction in NO and PGE2 production in THP-1 cells.
- 27 March 2023
- Published by Wiley
Open AccessAlcoholic Extract S.lavandulifolia Vahl Suppress TNFα,IL-1β,COX2, iNOS Gene Expression, and PGE2 and NO Production in Bovine Fibroblas-Like Synoviocyte and THP1
Osteoarthritis (OA) , known as an inflammatory disease, affects the quality of life of countless people all around the world. In this ex vivo study, the anti-inflammatory effects of alcoholic extract S. lavandulifolia Vahl were investigated. Anti-inflammatory effects S. lavandulifolia Vahl. was evaluated based on measuring the levels of mRNA expression of pro-inflammatory genes including TNF-α , iL-1β , COX-2, and iNOS in bovine fibroblast-like synoviocytes and the levels of NO and PGE2 in Human THP-1 cells. Cells were treated with 100 ng/ml LPS in both the absence and presence of Alcoholic Extract S. lavandulifolia Vahl (AESL) (7.5µg/ml) that had no cytotoxic effects, as measured with MTT and trypan blue assays. Results showed that S. lavandulifolia Vahl. downregulated TNF-α (41.24%), iL-1β (47.12%), COX-2 (44.92%), and iNOS (45.34%) expression in BFLS, downregulated TNF-α (56.8%), iL-6 (58.04%) and iL-18 (52.59%) in THP-1 activated cells and this suppression was paralleled by a significant reduction in PGE2 (52.12%) and NO (51.06%) in cellular supernatant of THP-1. For the first time, our results suggested that S. lavandulifolia Vahl exerts has anti-inflammatory effects through the suppression of TNF-α, IL-1β, COX-2, and iNOS in bovine fibroblast synoviocytes along with the reduction in NO and PGE2 production in THP-1 cells.
- Open Access
- 1 June 2019
- Published by CMV Verlag in Journal of Ilam University of Medical Sciences
- Vol. 27 (2) , 135-147
Reduced TNF-α, IL-1β and COX-2 Expressions and Decreased Production Rate of PGE2 and NO in Articular Chondrocytes of Monocyte/Macrophage using the Aqueous Extract Alhagi Maurorum L.
- 1 June 2019
- Published by CMV Verlag in Journal of Ilam University of Medical Sciences
- Vol. 27 (2) , 135-147
Open AccessReduced TNF-α, IL-1β and COX-2 Expressions and Decreased Production Rate of PGE2 and NO in Articular Chondrocytes of Monocyte/Macrophage using the Aqueous Extract Alhagi Maurorum L.
- Open Access
- 15 October 2018
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 22 (12) , 6401-6404
Some of the effective factors in the pathogenesis of gastro‐oesophageal reflux disease
Oesophageal adenocarcinoma is one of the most fatal tumours to affect the digestive tract and is the eighth most common malignancy worldwide. Gastro‐oesophageal reflux has an important role in the incidence of adenocarcinoma of the oesophagus. Gastro‐oesophageal reflux disease (GERD) is a multifactorial, acid‐peptic disorder that results from the reflux of noxious material from the stomach into the oesophagus. The refluxed material causes the occurrence of oesophageal inflammation which creates a condition that is called reflux oesophagitis. The prevalence of this disease has increased dramatically in recent decades, mostly in the western world, where it affects about 10% to 30% of the population. The aetiology of oesophageal mucosal damage is complicated. Many inflammatory mediators are produced within the gastrointestinal (GI) tract, but their contributions in pathophysiology and disease pathogenesis have not been well investigated. Despite the protective barrier provided by the oesophageal mucosa, refluxed materials can cause oxidative injury and in?ammatory responses that involve the epithelium and immune cells. The analysing cellular events in gastro‐ oesophageal reflux disease and physiological responses to such conditions are important and necessary for a better grasp of the pathogenesis of GERD and the expansion of new treatments. Therefore, we want to discuss some of the important and key factors of GERD disease in this article.
- 15 October 2018
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 22 (12) , 6401-6404
Open AccessSome of the effective factors in the pathogenesis of gastro‐oesophageal reflux disease
Oesophageal adenocarcinoma is one of the most fatal tumours to affect the digestive tract and is the eighth most common malignancy worldwide. Gastro‐oesophageal reflux has an important role in the incidence of adenocarcinoma of the oesophagus. Gastro‐oesophageal reflux disease (GERD) is a multifactorial, acid‐peptic disorder that results from the reflux of noxious material from the stomach into the oesophagus. The refluxed material causes the occurrence of oesophageal inflammation which creates a condition that is called reflux oesophagitis. The prevalence of this disease has increased dramatically in recent decades, mostly in the western world, where it affects about 10% to 30% of the population. The aetiology of oesophageal mucosal damage is complicated. Many inflammatory mediators are produced within the gastrointestinal (GI) tract, but their contributions in pathophysiology and disease pathogenesis have not been well investigated. Despite the protective barrier provided by the oesophageal mucosa, refluxed materials can cause oxidative injury and in?ammatory responses that involve the epithelium and immune cells. The analysing cellular events in gastro‐ oesophageal reflux disease and physiological responses to such conditions are important and necessary for a better grasp of the pathogenesis of GERD and the expansion of new treatments. Therefore, we want to discuss some of the important and key factors of GERD disease in this article.